Unicycive Therapeutics, Inc.
UNCYNext catalyst
Oxylanthanum Carbonate
Chronic Kidney Disease Requiring Chronic Dialysis
Get an email about UNCY's next catalysts
Track Unicycive Therapeutics (UNCY) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.
Plus 2 more upcoming events in our data (earnings, NDA filing).See the timeline
3 upcoming, 1 past
UNCY Earnings Report
Date estimated from past reporting pattern, not yet confirmed by the company | EPS Est: $-0.33 | FQ end Sep/2026 | Call: tbd
FDA PDUFA Date Oxylanthanum Carbonate
Extracted from news: Unicycive Therapeutics Announces FDA Acceptance of Oxylanthanum Carbonate New Drug Application Resub
SourceNDA Filing - Oxylanthanum Carbonate
Unicycive Therapeutics announced that the FDA accepted its resubmitted New Drug Application for oxylanthanum carbonate, with a PDUFA target action date of March 25, 2027.
SourceUpcoming FDA decisions
How UNCY's past catalysts played out
Market Overview
Stock performance and key metrics
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Oxylanthanum Carbonate | Phase 2 | Chronic Kidney Disease Requiring Chronic Dialysis | - | Patent 2030 |
Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)
Frequently asked questions
What is in Unicycive Therapeutics, Inc.'s drug pipeline?→
CatalystAlert tracks 1 drug candidate in Unicycive Therapeutics, Inc.'s (UNCY) pipeline across Phase 2. Its lead program is Oxylanthanum Carbonate (Phase 2). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Unicycive Therapeutics, Inc.'s next FDA catalyst?→
Unicycive Therapeutics, Inc.'s (UNCY) next tracked catalyst is a PDUFA date expected Mar 25, 2027. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.
How do I track UNCY biotech catalysts?→
Add UNCY to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Unicycive Therapeutics, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.